Literature DB >> 29404090

Determination of Factors Affecting Mortality of Patients with Sepsis in a Tertiary Intensive Care Unit.

Baran Balcan1, Şehnaz Olgun2, Fatih Torlak3, Seda Beyhan Sağmen2, Emel Eryüksel2, Sait Karakurt2.   

Abstract

OBJECTIVES: Sepsis is a disease with high mortality that is frequently observed in intensive care units. This study aimed to determine the risk factors affecting mortality of patients with sepsis who were followed up in the intensive care unit (ICU). We aimed to contribute to literature by evaluating the relationship between mortality and pro-brain natriuretic peptide (pro-BNP9), C-reactive protein (CRP), thrombocyte count, Acute Physiology and Chronic Health Evaluation (APACHE) II score, Sequential Organ Failure Assessment (SOFA) score, duration of hospitalization in the intensive care unit, and the presence of multidrug-resistant microorganism.
MATERIAL AND METHODS: Patients hospitalized in ICU because of the diagnosis of sepsis and septic shock between December 2010 and June 2012 were included in this retrospective study.
RESULTS: A total of 141 patients, including 74 male (52.5%) and 67 female (47.5%) patients, were involved in the study, and the median age was 66.8±17.9 years. Sixty-nine patients (48.9%) were discharged from the ICU; however, 72 patients (51.1%) were exitus. Multidrug-resistant microorganism was detected in 34 patients (24.1%). The patients' median SOFA score was 9.16±3.16, median APACHE-II score was 24.9±7.83, and median duration of hospitalization in the ICU was 8.44±11.61 days. It was found that mortality rate significantly increased in patients with the APACHE-II score of 24.5 and over, SOFA score of 8.5 and over, pro BNP value of 7241 ng/L and over, and CRP value of 96.5 mg/dL and over. Mortality rate was detected to be higher in patients undergoing invasive mechanical ventilation than in patients undergoing non-invasive mechanical ventilation. When thrombocyte count and mortality were associated with each other, it was found that the median value was 86000 mg/dL in exitus patients, whereas it was 185000 mg/dL in patients discharged from the ICU.
CONCLUSION: It was revealed that increased APACHE-II score, increased SOFA score, increased pro BNP score, increased CRP, the presence of multidrug-resistant microorganism, and decreased thrombocyte count elevated the rate of mortality. However, no relationship was observed between the duration of hospitalization in the ICU and mortality.

Entities:  

Keywords:  Sepsis; intensive care; mortality

Year:  2015        PMID: 29404090      PMCID: PMC5793766          DOI: 10.5152/ttd.2015.4510

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  20 in total

1.  Performance assessment of Acute Physiology and Chronic Health Evaluation II and Simplified Acute Physiology Score II in a referral respiratory intensive care unit in Iran.

Authors:  Lida Fadaizadeh; Ronak Tamadon; Kayvan Saeedfar; Hamid Reza Jamaati
Journal:  Acta Anaesthesiol Taiwan       Date:  2012-06-23

2.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.

Authors:  Ursula Hoffmann; Martina Brueckmann; Thomas Bertsch; Mike Wiessner; Claudia Liebetrau; Siegfried Lang; Karl K Haase; Martin Borggrefe; Guenter Huhle
Journal:  Clin Lab       Date:  2005       Impact factor: 1.138

4.  Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis.

Authors:  G P Castelli; C Pognani; M Cita; A Stuani; L Sgarbi; R Paladini
Journal:  Minerva Anestesiol       Date:  2006 Jan-Feb       Impact factor: 3.051

5.  Noninvasive versus conventional mechanical ventilation. An epidemiologic survey.

Authors:  A Carlucci; J C Richard; M Wysocki; E Lepage; L Brochard
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

6.  Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; A de Mendonça; F Cantraine; R Moreno; J Takala; P M Suter; C L Sprung; F Colardyn; S Blecher
Journal:  Crit Care Med       Date:  1998-11       Impact factor: 7.598

7.  Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma.

Authors:  Gian Paolo Castelli; Claudio Pognani; Massimo Cita; Rolando Paladini
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

Review 8.  The immunopathogenesis of sepsis.

Authors:  Jonathan Cohen
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  Comparison of procalcitonin and C-reactive protein as markers of sepsis.

Authors:  Aldo Luzzani; Enrico Polati; Romolo Dorizzi; Alessio Rungatscher; Raffaella Pavan; Alberto Merlini
Journal:  Crit Care Med       Date:  2003-06       Impact factor: 7.598

10.  Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia.

Authors:  H Aydemir; D Akduman; N Piskin; F Comert; E Horuz; A Terzi; F Kokturk; T Ornek; G Celebi
Journal:  Epidemiol Infect       Date:  2012-09-07       Impact factor: 4.434

View more
  2 in total

Review 1.  Natriuretic Peptides to Predict Short-Term Mortality in Patients With Sepsis: A Systematic Review and Meta-analysis.

Authors:  Saarwaani Vallabhajosyula; Zhen Wang; M Hassan Murad; Shashaank Vallabhajosyula; Pranathi R Sundaragiri; Kianoush Kashani; Wayne L Miller; Allan S Jaffe; Saraschandra Vallabhajosyula
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-01-08

2.  Global epidemiology of septic shock: a protocol for a systematic review and meta-analysis.

Authors:  Frank Leonel Tianyi; Joel Noutakdie Tochie; Celestin Danwang; Aime Mbonda; Mazou N Temgoua; Sylvester Yari Mapoh; Njinkeng J Nkemngu; Esther Tallah; Jean Joel Bigna
Journal:  BMJ Open       Date:  2019-11-14       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.